IRIS
CLERICO, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59.867
EU - Europa 36.716
AS - Asia 21.427
SA - Sud America 3.580
Continente sconosciuto - Info sul continente non disponibili 431
AF - Africa 413
OC - Oceania 33
Totale 122.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 58.250
GB - Regno Unito 14.502
SG - Singapore 7.875
RU - Federazione Russa 6.676
CN - Cina 6.087
IT - Italia 4.325
UA - Ucraina 3.967
VN - Vietnam 3.132
BR - Brasile 2.860
DE - Germania 2.433
HK - Hong Kong 1.933
CA - Canada 1.157
SE - Svezia 975
FI - Finlandia 933
FR - Francia 870
DK - Danimarca 784
PL - Polonia 642
BD - Bangladesh 543
IN - India 376
IL - Israele 272
AR - Argentina 245
MX - Messico 206
IE - Irlanda 204
EU - Europa 202
ZA - Sudafrica 156
TR - Turchia 150
IQ - Iraq 146
ID - Indonesia 142
EC - Ecuador 113
JP - Giappone 100
VE - Venezuela 96
PK - Pakistan 93
CO - Colombia 92
NL - Olanda 88
ES - Italia 73
SA - Arabia Saudita 68
CL - Cile 66
KR - Corea 65
UZ - Uzbekistan 61
JM - Giamaica 57
MA - Marocco 56
MY - Malesia 53
PH - Filippine 45
RO - Romania 39
AE - Emirati Arabi Uniti 37
CR - Costa Rica 35
PY - Paraguay 35
JO - Giordania 34
TN - Tunisia 34
KE - Kenya 33
LT - Lituania 33
UY - Uruguay 33
EG - Egitto 30
NP - Nepal 29
TT - Trinidad e Tobago 28
AT - Austria 25
DZ - Algeria 25
HN - Honduras 24
AU - Australia 23
NI - Nicaragua 22
ET - Etiopia 21
PE - Perù 20
AZ - Azerbaigian 18
SK - Slovacchia (Repubblica Slovacca) 18
IR - Iran 15
KZ - Kazakistan 15
PA - Panama 15
TH - Thailandia 15
OM - Oman 14
PT - Portogallo 14
TW - Taiwan 14
BO - Bolivia 13
GT - Guatemala 13
PR - Porto Rico 13
RS - Serbia 13
AL - Albania 12
BH - Bahrain 12
SV - El Salvador 12
CH - Svizzera 11
DO - Repubblica Dominicana 11
PS - Palestinian Territory 11
BB - Barbados 10
BE - Belgio 9
BY - Bielorussia 9
CZ - Repubblica Ceca 9
LB - Libano 9
CI - Costa d'Avorio 8
KW - Kuwait 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
QA - Qatar 8
AM - Armenia 7
AO - Angola 7
BG - Bulgaria 7
HR - Croazia 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
KH - Cambogia 6
HU - Ungheria 5
KG - Kirghizistan 5
Totale 122.131
Salva come PNG Salva come JPEG
Città #
Southend 12.638
Dallas 8.342
Woodbridge 5.122
Ann Arbor 4.000
Singapore 3.516
San Jose 3.461
Chandler 3.261
Houston 3.034
Ashburn 2.642
San Mateo 2.513
Beijing 2.409
Council Bluffs 2.379
Dearborn 1.956
Jacksonville 1.931
Hong Kong 1.830
Falls Church 1.474
Moscow 1.402
Fairfield 1.187
The Dalles 1.153
Seattle 1.069
Cambridge 949
Wilmington 847
Milan 830
Dong Ket 828
Stevenage 762
Portsmouth 694
Hefei 689
Boardman 665
Warsaw 623
Lawrence 611
Los Angeles 596
Ho Chi Minh City 566
Lauterbourg 560
Brooklyn 538
Rome 524
Pisa 471
Ottawa 462
Chicago 437
Hanoi 403
Santa Clara 395
New York 332
Buffalo 305
Helsinki 297
São Paulo 296
Phoenix 269
Tel Aviv 249
Montréal 195
Dublin 189
Old Bridge 185
Salt Lake City 177
San Diego 143
Figino 119
Beauharnois 107
Mexico City 105
Montreal 104
Redwood City 101
Rio de Janeiro 101
Munich 99
Norwalk 97
Orem 94
London 90
Tampa 90
Toronto 88
Johannesburg 86
Tokyo 86
Da Nang 85
Chennai 83
Naples 75
Atlanta 74
Elk Grove Village 74
Stockholm 68
Denver 67
Haiphong 64
Turin 63
Belo Horizonte 61
Bologna 57
Brasília 54
Tashkent 54
Boston 53
Columbus 53
San Francisco 53
Baghdad 51
Frankfurt am Main 51
Dhaka 50
Florence 50
Curitiba 49
Miami 46
Porto Alegre 45
Guangzhou 44
Hải Dương 42
Amsterdam 40
Fremont 40
Kansas City 40
Washington 40
Augusta 39
Poplar 39
Seoul 39
Istanbul 38
Manchester 38
Charlotte 37
Totale 83.629
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.721
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 710
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 504
siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II 478
Downregulation of von Willebrand Factor prevents Ang II-induced endothelin-1 expression independently of eNOS activation in porcine endothelial cells 460
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. 417
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 381
A chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using quality control sera assayed in an interlaboratory survey 353
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study 352
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 346
Inibizione dell'asse ipofiso-gonadale dopo trattamento con un farmaco anabolizzante (Metandrostenolone, Dianabol) 342
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 342
125I-Endothelin-1 binding sites in human cardiac tissue 341
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 340
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 339
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 339
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 337
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides 326
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 325
A chromatographic method for the determination of uric acid turnover in man 322
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 317
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 315
A sensitive and accurate plasma noradrenaline assay using a modified fluorimetric method. 313
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 310
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 308
A ligand-receptor binding assay of urinary and circulating endogenous digitalis-like factors 306
A simplified method of measuring free triiodothyronine in serum by conbined equilibrium dialysis and gel Sephadex extraction 301
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 301
A chromatographic method for the determination of uric acid turnover in man 299
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 298
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 295
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 295
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 294
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 293
Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data 287
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. 286
A false positive case of cardiac troponin I: Which diagnostic approach? 286
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 286
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 284
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 281
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients 279
Marcatori di rimodellamento e fibrosi cardiaca 279
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 278
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 278
A new chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using QC sera assayed in an interlaboratory survey 277
A simple, sensitive and rapid radioimmunoassay for measurement of urinary albumin 277
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 276
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 276
Acute effects of intravenous amiodarone on sulphate metabolite of thyroid hormones in arrhythmic patients 274
A rapid procedure for the quantization of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects 273
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 273
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 271
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 270
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 269
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 269
B-type natriuretic peptide secretion following scuba diving 267
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 266
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 264
Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practice 264
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 261
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 258
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences 256
The 99th percentile of reference population for cTnI and cTnT assay: Methodology, pathophysiology and clinical implications 255
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 254
Methodological assessment of mitochondrial respiratory chain-enzyme activities in cardiac tissue 254
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 254
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 251
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 251
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 251
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 251
Evaluation of analytical performances using standardized analytical protocols and comparison of clinical results of the new ADVIA BNP and NT-proBNP immunoassays for the Centaur XPT platform 251
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 250
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 249
Evaluation and Comparison with Other High-Sensitivity Methods of Analytical Performance and Measured Values of a New Laboratory Test for Cardiac Troponin I Assay 248
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 248
Natriuretic peptide testing in primary care patients. 248
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 248
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin i 244
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 243
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 242
S-nitrosoglutathione as a substrate of gamma-glutamyltransferase (GGT)- A kinetic study 242
No variation in Hsp70 mRNA level during cardiac surgery in pediatric patients evaluated by semiquantitative RT-PCR 241
Proposta per l’utilizzo in Pronto Soccorso delle troponine cardiache misurate con metodi di ultima generazione in pazienti con sospetto di sindrome coronarica acuta senza sopraslivellamento del tratto ST 239
Cardiac troponins as biomarkers for cardiac disease 239
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. 237
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 237
Comparison of two BNP immunoassays using the same antibodies and standard materials 237
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty 236
BNP values in the first days of life measured with an automated immunoassay platform 236
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 236
Genomic medicine and thrombotic risk: who, when, how and why? 236
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 236
New biomarkers for risk stratifications in patients with heart failure: high-sensitivity troponin I and galectin-3 236
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications 234
Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. 234
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 233
New and emerging biomarkers of heart failure 231
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction 230
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 229
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 229
Totale 30.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 600.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 600.012
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.872 0 0 0 966 62 55 887 1.779 511 924 56 632
2022/20236.603 616 117 70 1.176 1.151 1.248 12 531 1.101 143 267 171
2023/20241.761 370 85 290 104 72 276 232 72 25 47 29 159
2024/202516.831 116 65 1.084 346 275 1.163 2.348 5.046 1.570 1.069 2.463 1.286
2025/202636.457 1.629 7.932 3.339 3.207 3.369 2.012 6.125 1.660 1.684 2.521 940 2.039
2026/20276.180 631 1.598 3.022 929 0 0 0 0 0 0 0 0
Totale 122.467